Iterum Therapeutics Plc (ITRM)

$1.41 0.07 (4.73%)

16:00 EDT ITRM Stock Quote Delayed 30 Minutes

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024

By InvestorPlace Earnings May 13, 2024

ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Volume:

Previous Close -

Market Cap 18.39M

PE Ratio -1.48

EPS -0.95

Volume (Avg. Vol.) 177,590

Day's Range $1.36 - $1.53

52-Week Range $0.62 - $2.50

Dividend & Yield N/A (N/A)

ITRM Stock Predictions, Articles, and Iterum Therapeutics Plc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 17, 2022

We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 12, 2022

Good morning, traders! Investors seeking news of the biggest pre-market stock movers for Tuesday are in the right place.

Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?

By William White, InvestorPlace Writer Jul 11, 2022

Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 28, 2022

We've got another busy week of trading ahead of us so let's start it off with the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 27, 2021

Good morning, trader! We're halfway through the week and still starting it with a breakdown of the biggest pre-market stock movers.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 1, 2021

Good morning, investor! The final day of the workweek is here and with it comes a look at the pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 30, 2021

Good morning, trader! We're starting off your Thursday the right way with a look at the biggest pre-market stock movers for today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 29, 2021

Good morning, investor! Get ready for another busy day of trading today with a look at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 28, 2021

Good morning! We're halfway through the week and still going strong with a look at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 2, 2021

Good morning! There's trading to do and we're starting the day off with a look at the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 28, 2021

We've got one more day of trading left in the week and we're starting it off with the biggest-pre-market stock movers for Friday!

Iterum Therapeutics Stock Looks Like a High-Risk Name Here

By Larry Ramer, InvestorPlace Contributor Mar 22, 2021

The fact that other antibiotic makers have declared bankruptcy in recent years is a negative sign for Iterum. Long-term investors should avoid ITRM stock.

Iterum Therapeutics’ Science Won’t Prevent Its Volatility

By Josh Enomoto, InvestorPlace Contributor Mar 18, 2021

Fundamentally, ITRM stock is an excellent play on multi-drug resistance pathogen solutions but you must also be aware of its extreme boom-bust cycles.

Unfavorable Earnings Profile Doesn’t Bode Well for Iterum Therapeutics Stock

By David Moadel, InvestorPlace Contributor Mar 2, 2021

It's encouraging that Iterum's oral antibiotic has blockbuster status potential, but the basic earnings data on ITRM stock signal caution.

ITRM Stock: 7 Things for Investors to Know About Iterum Therapeutics as Shares Surge

By William White, InvestorPlace Writer Feb 9, 2021

Iterum Therapeutics (ITRM) stock is taking off on Tuesday with heavy trading even without any news coming from the company.

Iterum Therapeutics News: Why ITRM Stock Is Rocketing Higher Today

By William White, InvestorPlace Writer Dec 3, 2020

Iterum Therapeutics (ITRM) is in the news Thursday following news of massive stakes in the company pushing ITRM stock higher.

Iterum meets main goal in late trial for uUTI treatment with oral sulopenem (NASDAQ:ITRM)

From Seeking Alpha Jan 30, 2024

Iterum Therapeutics announced positive results from a phase 3 trial comparing oral sulopenem to Augmentin in women with urinary tract infections.

Iterum Therapeutics regains compliance with Nasdaq's minimum bid price rule (NASDAQ:ITRM)

From Seeking Alpha Dec 4, 2023

Pharmaceutical company Iterum Therapeutics regains compliance with Nasdaq's minimum bid price rule, meeting the requirement after a non-compliance notice.

Iterum Therapeutics director discloses purchase of 20K shares (NASDAQ:ITRM)

From Seeking Alpha Nov 28, 2023

Iterum Therapeutics director Michael W Dunne acquires 20k shares for $40,690, joining a series of insider trades on ITRM in the past year.

H.C. Wainwright Keeps Their Hold Rating on Iterum Therapeutics (ITRM)

From TipRanks Nov 11, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Iterum Therapeutics (ITRM – Research Report). The company’s shares ...

H.C. Wainwright Remains a Hold on Iterum Therapeutics (ITRM)

From TipRanks Oct 26, 2022

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Iterum Therapeutics (ITRM – Research Report) on October 21. The company’s shares closed yest...

Analysts Offer Insights on Healthcare Companies: Puma Biotechnology (PBYI) and Iterum Therapeutics (ITRM)

From TipRanks Sep 21, 2022

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Puma Biotechnology (

Iterum Therapeutics Plc (ITRM)

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Iterum Therapeutics Plc (ITRM)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ITRM Stock Predictions, Articles, and Iterum Therapeutics Plc News

Subscriber Sign in